A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 20, 2014

Primary Completion Date

March 24, 2014

Study Completion Date

March 24, 2014

Conditions
Healthy
Interventions
DRUG

ALXN1840

ALXN1840 (60 milligrams) was administered orally as non-coated capsules at Hour 0 on Day 1.

DRUG

Omeprazole

Omeprazole (20 milligrams) was administered orally as a delayed-release capsule in the morning of Days -5 to -1 and at Hour -1 on Day 1.

Trial Locations (1)

68502

Clinical Trial Site, Lincoln

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY